Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Corticosteroids systemic

Pharmacotherapy has an important role in managing AR symptoms (Table 59-2). Intranasal corticosteroids, systemic and topical antihistamines and decongestants, mast cell stabilizers, and immunotherapy all are beneficial in treating symptoms of AR.9 Antihistamines and intranasal corticosteroids are considered first-line therapy for AR, whereas decongestants, mast cell stabilizers, leukotriene modifiers, and systemic corticosteroids are secondary treatment options10-12 (Fig. 59-2). Whenever exposure to allergens can be predicted (e.g., SAR or visiting homes with a pet), medications should be used pro-phylactically to maximize effectiveness.11... [Pg.928]

CNS prophylaxis relies on intrathecal chemotherapy (e.g., methotrexate, cytarabine, and corticosteroids), systemic... [Pg.1406]

The corticosteroids are effective in most children and adults with asthma. They are beneficial for the treatment of both acute and chronic aspects of the disease. Inhaled corticosteroids, including triamcinolone ace-tonide (Azmflcort),beclomethasone dipropionate (Beclo-vent, Vancerit), flunisolide AeroBid), and fluticasone (Flovent), are indicated for maintenance treatment of asthma as prophylactic therapy. Inhaled corticosteroids are not effective for relief of acute episodes of severe bronchospasm. Systemic corticosteroids, including prednisone and prednisolone, are used for the short-term treatment of asthma exacerbations that do not respond to (32-adrenoceptor agonists and aerosol corticosteroids. Systemic corticosteroids, along with other treatments, are also used to control status asthmaticus. Because of the side effects produced by systemically administered corticosteroids, they should not be used for maintenance therapy unless all other treatment options have been exhausted. [Pg.465]

Posterior segment disease is unaffected by topical therapy and minimally requires periorbital administration of corticosteroids systemic therapy is needed if the condition is bilateral or sight threatening. Indications for posterior segment treatment include significant vision loss from macular edema or severe vitreitis, choroidal granulomas, optic nerve involvement, or retinal neovascularization. Conversely, if vision remains at 20/40 or better and there are no complicating factors, systemic... [Pg.631]

Hypersensitivity to any corticosteroid, systemic fungal infection, peptic ulcers (except life-threatening situations). Avoid live virus vaccine such as smallpox. [Pg.134]

Category Corticosteroid, systemic Corticosteroid, topical Half-life N/A... [Pg.170]

Complex interactions between 5-HT and corticosteroid systems in the central nervous system (CNS) are only now begiiming to be understood, and may account for some of the relationships between the effects of stress, mood dysregnlation and cognitive dysfunction encoimtered in depressive disorder. [Pg.69]

Topical skin Protectant (TSP) Reactive TSP (decontaminates) Corticosteroids (systemic)... [Pg.157]

Persistent erythema, due to angiogenic factors stimulating vasodilatation, is considered a physiological event if it occurs within 3 weeks after the peel procedure [6]. If erythema associated with pruritus persists for more than 3 weeks, treatment with potent topical corticosteroids, systemic corticosteroids, and/or intralesional corticosteroids should be administered. Silicone sheets or pulsating dye laser treatments may be also adopted, especially when evident thickening or scarring has occurred [6, 15]. [Pg.203]

In 1973 D-homo corticosteroids (109—112), eg, D-homo-9a- uoroprednisolone acetate (111) were reported to have antiinflammatory activity (107). Compounds such as 21-acetoxy-liP- uoto-9a-chloto-17aa-hydtoxy-D-homo-ptegn-4-en-3,20-dione (110) had especially strong topical activity with weak systemic activity (108). Other preparations of D-homocorticoids included... [Pg.106]

There are hundreds of topical steroid preparations that are available for the treatment of skin diseases. In addition to their aforementioned antiinflammatory effects, topical steroids also exert their effects by vasoconstriction of the capillaries in the superficial dermis and by reduction of cellular mitosis and cell proliferation especially in the basal cell layer of the skin. In addition to the aforementioned systemic side effects, topical steroids can have adverse local effects. Chronic treatment with topical corticosteroids may increase the risk of bacterial and fungal infections. A combination steroid and antibacterial agent can be used to combat this problem. Additional local side effects that can be caused by extended use of topical steroids are epidermal atrophy, acne, glaucoma and cataracts (thus the weakest concentrations should be used in and around the eyes), pigmentation problems, hypertrichosis, allergic contact dermatitis, perioral dermatitis, and granuloma gluteale infantum (251). [Pg.446]

Table 2. Total Worldwide Sales of Systemic Sex Hormones and Corticosteroids... Table 2. Total Worldwide Sales of Systemic Sex Hormones and Corticosteroids...
Inhaled steroids (commonly used are beclomethasone, budesonide, triamcinolone, fluticasone, flunisolide) appear to attenuate the inflammatory response, to reduce bronchial hyperreactivity, to decrease exacerbations and to improve health status they may also reduce the risk of myocar dial infar ction, but they do not modify the longterm decline in lung function. Whether- steroids affect mortality remains unclear. Many patients appear to be resistant to steroids and large, long-term trials have shown only limited effectiveness of inhaled corticosteroid ther apy. Certainly, the benefit from steroids is smaller in COPD than in asthma. Topical side-effects of inhaled steroids are oropharyngeal candidiasis and hoarse voice. At the normal doses systemic side-effects of inhaled steroids have not been firmly established. The current recommendation is that the addition of inhaled gluco-coiticosteroids to bronchodilator treatment is appropriate for patients with severe to veiy sever e COPD. [Pg.365]

CRH (Corticotropin releasing hormone) is expressed in the nucleus paraventricularis of the hypothalamus and drives the stress hormone system by activating synthesis and release of corticotropin at the pituitary and in turn corticosteroid from the adrenal cortex. CRH is also expressed at many other brain locations not involved in neuroendocrine regulation, e.g. the prefrontal cortex and the amygdala. Preclinical studies have shown that CRH also coordinates the behavioral adaptation to stress (e.g. anxiety, loss of appetite, decreased sleepiness, autonomic changes, loss of libido). [Pg.397]

The topical and oral use of retinoids for treatment of hyperkeratotic disorders such as psoriasis and Darier s disease has long been established. Systemic retinoid therapy is often combined with topical diugs such as corticosteroids, dithranol, tar, and also UVA/UVB phototherapies where synergistic effects have been reported. [Pg.1073]

Maintenance and prophylactic treatment of asthma for asthma patients who require systemic corticosteroid administration when adding an inhaled corticosteroid may reduce or eliminate the need for systemic corticosteroids... [Pg.339]

Vaccinations containing live organisms are not administered within 3 months of immune globulin administration because antibodies in the globulin preparation may interfere with the immune response to the vaccination. Corticosteroids, antineoplastic dru, and radiation therapy depress the immune system to such a degree that insufficient numbers of antibodies are produced to prevent the disease. When the salicylates are administered with the varicella vaccination, there is an increased risk of Reye s syndrome developing. [Pg.580]

Gentian violet solution is used to delineate the areas to be treated. Refrigerant topical anesthesia is used to freeze the skin prior to the procedure. Holding the skin taut, the dermabrader treats one anatomic unit at a time. Post-operatively, patients may have an open or closed dressing system, use antiviral agents, antibacterials and corticosteroids. The re-epithelialization is complete in 5-7 days and residual erythema is common for up to 4 weeks. [Pg.127]


See other pages where Corticosteroids systemic is mentioned: [Pg.220]    [Pg.612]    [Pg.443]    [Pg.219]    [Pg.374]    [Pg.473]    [Pg.474]    [Pg.302]    [Pg.247]    [Pg.220]    [Pg.612]    [Pg.443]    [Pg.219]    [Pg.374]    [Pg.473]    [Pg.474]    [Pg.302]    [Pg.247]    [Pg.106]    [Pg.40]    [Pg.282]    [Pg.441]    [Pg.445]    [Pg.446]    [Pg.446]    [Pg.448]    [Pg.448]    [Pg.247]    [Pg.256]    [Pg.142]    [Pg.77]    [Pg.272]    [Pg.1083]    [Pg.1179]    [Pg.338]    [Pg.347]    [Pg.524]    [Pg.121]    [Pg.268]    [Pg.269]   
See also in sourсe #XX -- [ Pg.387 ]

See also in sourсe #XX -- [ Pg.886 , Pg.886 , Pg.888 , Pg.888 , Pg.888 ]




SEARCH



Corticosteroid systemic effects

Corticosteroid therapy systemic preparations

Endocrine system systemic corticosteroids

Nervous system drugs corticosteroids

Systemic corticosteroid therapy

Systemic lupus erythematosus corticosteroids

© 2024 chempedia.info